Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022-2023.

Adenoviruses molecular epidemiology multicenter surveillance pediatric infection respiratory infections

Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
21 Jul 2024
Historique:
received: 24 04 2024
revised: 15 07 2024
accepted: 18 07 2024
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 23 7 2024
Statut: aheadofprint

Résumé

Human adenoviruses are the causative agents of 5-7% of viral respiratory infections, mainly caused by species B and C. They can infect all age groups, but children are usually at high risk of infections. Adenovirus epidemiology is well documented in East-Asian countries but little is known about adenovirus circulation in Europe in recent years. This multicentre retrospective study aimed to investigate the circulation and molecular epidemiology of hAdVs. This surveillance collected a total of 54463 respiratory specimens between January 1 2022 and June 20 2023 were tested for the presence of respiratory viruses. Our results showed that adenovirus was detected in 6.6% of all cases of acute respiratory infection included in the study and the median age of positive patients was 3 years, with male children in 1-2 years age group being the most affected. 43.5% of adenovirus cases were co-infected with at least one other respiratory virus, and rhinovirus was co-detected in 54% of cases. Genotyping of adenovirus allowed the identification of 6 different genotypes circulating in Italy, among which type B3 was the most frequently detected.

Identifiants

pubmed: 39043318
pii: S1341-321X(24)00195-8
doi: 10.1016/j.jiac.2024.07.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Auteurs

Federica A M Giardina (FAM)

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: federica.giardina01@universitadipavia.i.

Laura Pellegrinelli (L)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. Electronic address: laura.pellegrinelli@unimi.it.

Federica Novazzi (F)

Department of Medicine and Innovation Technology, University of Insubria (DIMIT), Varese, Italy; Laboratory of Medical Microbiology and Virology University Hospital of Varese, Varese, Italy. Electronic address: federica.novazzi@asst-settelaghi.it.

Elisa Vian (E)

UOC Microbiology Treviso Hospital, Department of specialist and laboratory medicine, AULSS 2 La Marca, Italy. Electronic address: elisa.vian@aulss2.veneto.it.

Valeria Biscaro (V)

UOC Microbiology Treviso Hospital, Department of specialist and laboratory medicine, AULSS 2 La Marca, Italy. Electronic address: valeria.biscaro@aulss2.veneto.it.

Cristina Russo (C)

Virology and Mycobacteria UOS, Microbiology and Diagnostic Immunology UOC, Bambino Gesù Children Hospital IRCCS, Roma, Italy. Electronic address: cristina.russo@opbg.net.

Stefania Ranno (S)

Virology and Mycobacteria UOS, Microbiology and Diagnostic Immunology UOC, Bambino Gesù Children Hospital IRCCS, Roma, Italy. Electronic address: stefania.ranno@opbg.net.

Elisabetta Pagani (E)

Laboratory of Microbiology and Virology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, Bolzano, Italy. Electronic address: elisabetta.pagani@sabes.it.

Elisa Masi (E)

Laboratory of Microbiology and Virology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, Bolzano, Italy. Electronic address: elisa.masi@sabes.it.

Claudia Tiberio (C)

UOC Microbiology and Virology, Cotugno Hospital AORN dei Colli, Naples, Italy. Electronic address: claudia.tiberio@ospedalideicolli.it.

Martina Esposito (M)

UOC Microbiology and Virology, Cotugno Hospital AORN dei Colli, Naples, Italy. Electronic address: martina.esposito030@gmail.com.

Sara Uceda Renteria (S)

Microbiology and Virology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: sara.ucedarenteria@policlinico.mi.it.

Annapaola Callegaro (A)

Microbiology and Virology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: annapaola.callegaro@policlinico.mi.it.

Giulia Piccirilli (G)

Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: giulia.piccirilli@aosp.bo.it.

Tiziana Lazzarotto (T)

Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Section of Microbiology, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Electronic address: tiziana.lazzarotto@unibo.it.

Francesca Rovida (F)

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: f.rovida@smatteo.pv.it.

Cristina Galli (C)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. Electronic address: cristina.galli@unimi.it.

Eleonora Lalle (E)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy. Electronic address: eleonora.lalle@inmi.it.

Fabrizio Maggi (F)

Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy. Electronic address: fabrizio.maggi@inmi.it.

Nicasio Mancini (N)

Department of Medicine and Innovation Technology, University of Insubria (DIMIT), Varese, Italy; Laboratory of Medical Microbiology and Virology University Hospital of Varese, Varese, Italy. Electronic address: nicasio.mancini@uninsubria.it.

Carla Acciarri (C)

Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy. Electronic address: carla.acciarri@ospedaliriuniti.marche.it.

Stefano Menzo (S)

Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy; Virology Unit, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy. Electronic address: s.menzo@staff.univpm.it.

Anna Maria Colacicco (AM)

Virology Laboratory - Microbiology and Virology Unit - University of Bari - Policlinic of Bari, Bari, Italy. Electronic address: annamaria.colacicco@uniba.it.

Maria Scarasciulli (M)

Virology Laboratory - Microbiology and Virology Unit - University of Bari - Policlinic of Bari, Bari, Italy. Electronic address: mluisascarasciulli52@gmail.com.

Antonio Piralla (A)

Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: antonio.piralla@unipv.it.

Fausto Baldanti (F)

Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy; Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Electronic address: f.baldanti@smatteo.pv.it.

Elena Pariani (E)

Department of Biomedical Sciences for Health, University of Milan, Milan, Italy. Electronic address: elena.pariani@unimi.it.

Classifications MeSH